Mark Edward Schnute,Gõran Mattias Wennerstål,James Robert Blinn,Neelu Kaila,James Richard Kiefer, JR.,Scot Richard Mente,Ravi G. Kurumbail,Marvin Jay Meyers,Atli Thorarensen,Li Xing,Christoph Wolfgang
申请号：
US16261689
公开号：
US20190144429A1
申请日:
2019.01.30
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention provides compounds, pharmaceutical compositions, methods of inhibiting RORγ activity and/or reducing the amount of IL-17 in a subject, and methods of treating various medical disorders using such compounds and pharmaceutical compositions.
